Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide

Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide

The novel coronavirus SARS-CoV-2 has become a global health concern. The morbidity and mortality of the potentially lethal infection caused by this virus arise from the initial viral infection and the subsequent host inflammatory response. The latter may lead to excessive release of pro-inflammatory...

Full description

Bibliographic Details
Main Authors: Zhiyu Wang, Yanfei Wang, Prachi Vilekar, Seung-Pil Yang, Mayuri Gupta, Myong In Oh, Autumn Meek, Lisa Doyle, Laura Villar, Anja Brennecke, Imindu Liyanage, Mark Reed, Christopher Barden, Donald F. Weaver
Format: Article
Language:English
Published: PeerJ Inc. 2020-07-01
Series:PeerJ
Subjects:
Furosemide
COVID-19
Cytokine storm
Hypercytokinemia
Coronavirus
Anti-inflammatory
Online Access:https://peerj.com/articles/9533.pdf

Internet

https://peerj.com/articles/9533.pdf

Similar Items